LGT Group Foundation’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Hold
19,824
0.01% 189
2025
Q4
$1.07M Sell
19,824
-2,219
-10% -$107K 0.01% 199
2025
Q3
$1.05M Sell
22,043
-5,988
-21% -$280K 0.01% 205
2025
Q2
$1.3M Sell
28,031
-2,561
-8% -$126K 0.02% 184
2025
Q1
$1.87M Buy
30,592
+718
+2% +$41.9K 0.03% 175
2024
Q4
$1.69M Sell
29,874
-18,855
-39% -$1.05M 0.03% 178
2024
Q3
$2.62M Sell
48,729
-6,279
-11% -$295K 0.04% 168
2024
Q2
$2.28M Sell
55,008
-60,907
-53% -$2.73M 0.04% 172
2024
Q1
$6.29M Sell
115,915
-166,912
-59% -$8.5M 0.15% 111
2023
Q4
$14.5M Sell
282,827
-37,018
-12% -$1.94M 0.32% 77
2023
Q3
$18.5M Sell
319,845
-178,687
-36% -$10.9M 0.46% 54
2023
Q2
$31.9M Buy
498,532
+5,114
+1% +$343K 0.77% 27
2023
Q1
$34.2M Sell
493,418
-82,954
-14% -$5.85M 0.98% 21
2022
Q4
$41.5M Buy
576,372
+30,795
+6% +$2.32M 1.3% 13
2022
Q3
$38.8M Sell
545,577
-17,965
-3% -$1.3M 1.51% 13
2022
Q2
$43.4M Buy
563,542
+36,815
+7% +$2.8M 1.32% 16
2022
Q1
$38.9M Buy
526,727
+345,432
+191% +$23.2M 0.91% 24
2021
Q4
$11.3M Buy
+181,295
New +$10.6M 0.29% 80

Other funds holding BMY

LGT Group Foundation's BMY Position: Q1 2026 in Review

LGT Group Foundation held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 19,824 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #189.

LGT Group Foundation first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $43.4M in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • LGT Group Foundation held 19,824 shares of Bristol-Myers Squibb worth $1.2M as of Q1 2026.
  • LGT Group Foundation left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.01% of LGT Group Foundation's portfolio in Q1 2026, its #189 holding.
  • LGT Group Foundation first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
  • LGT Group Foundation's Bristol-Myers Squibb position peaked at $43.4M in Q2 2022.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on LGT Group Foundation's 13F filing for Q1 2026, filed 28 Apr 2026.